EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Propranolol Reduces Parkinson's Tremor and Inhibits Tremor‐Related Activity in the Motor Cortex: A Placebo‐Controlled Crossover Trial

Anouk van der Heide iD, Maaike Wessel iD, Danae Papadopetraki iD, Dirk E M Geurts iD, Teije H van Prooije iD, Frank Gommans iD, Bastiaan R Bloem, Michiel F Dirkx, Rick C Helmich iD

Annals of Neurology · 2025-04 · 97 (4) · 741-752

DOI: 10.1002/ana.27159 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Annals of Neurology, online erschienen am 21.12.2024. Verfasst von Anouk van der Heide und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Centre of Expertise for Parkinson and Movement Disorders, Radboud University Medical Centre, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Propranolol, Tremor, Motor Cortex, Parkinson Disease. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nederlandse Organisatie voor Wetenschappelijk Onderzoek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Parkinson's disease (PD) resting tremor is thought to be initiated in the basal ganglia and amplified in the cerebello‐thalamo‐cortical circuit. Because stress worsens tremor, the noradrenergic system may play a role in amplifying tremor. We tested if and how propranolol, a non‐selective beta‐adrenergic receptor antagonist, reduces PD tremor and whether or not this effect is specific to stressful conditions.

Methods

In a cross‐over, double‐blind intervention study, participants with PD resting tremor received propranolol (40 mg, single dose) or placebo (counter‐balanced) on 2 different days. During both days, we assessed tremor severity (with accelerometry) and tremor‐related brain activity (with functional magnetic resonance imaging), as well as heart rate and pupil diameter, while subjects performed a stressful cognitive load task that has been linked to the noradrenergic system. We tested for effects of drug (propranolol vs placebo) and stress (cognitive load vs rest) on tremor power and tremor‐related brain activity.

Results

We included 27 PD patients with prominent resting tremor. Tremor power significantly increased during cognitive load versus rest ( F [1,19] = 13.8; p = 0.001; = 0.42) and decreased by propranolol versus placebo ( F [1,19] = 6.4; p = 0.02; = 0.25), but there was no interaction. We observed task‐related brain activity in a stress‐sensitive cognitive control network and tremor power‐related activity in the cerebello‐thalamo‐cortical circuit. Propranolol significantly reduced tremor‐related activity in the motor cortex compared to placebo ( F [1,21] = 5.3; p = 0.03; = 0.20), irrespective of cognitive load.

Interpretation

Our findings indicate that propranolol has a general, context‐independent, tremor‐reducing effect that may be implemented at the level of the primary motor cortex. ANN NEUROL 2025;97:741–752

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PropranololTremorMotor CortexParkinson DiseaseAdrenergic beta-AntagonistsHumansMaleCross-Over StudiesFemaleDouble-Blind MethodMiddle AgedAgedMagnetic Resonance Imaging

Substanzen

PropranololAdrenergic beta-Antagonists

Autor:innen und Institutionen

  • Department of Neurology, Centre of Expertise for Parkinson and Movement Disorders, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Donders Institute for Brain, Cognition, and Behavior, Centre for Cognitive Neuroimaging, Radboud University Nijmegen, Nijmegen, The Netherlands.
  • Department of Psychiatry, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Department of Cardiology, Maxima Medical Centre, Veldhoven, The Netherlands.

ORCID-Profile: Anouk van der Heide, Maaike Wessel, Danae Papadopetraki, Dirk E M Geurts, Teije H van Prooije, Frank Gommans, Rick C Helmich

Förderung

  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Zitieren

APA

van der Heide, A., Wessel, M., Papadopetraki, D., Geurts, D. E. M., van Prooije, T. H., Gommans, F., Bloem, B. R., Dirkx, M. F., & Helmich, R. C. (2025). Propranolol Reduces Parkinson's Tremor and Inhibits Tremor‐Related Activity in the Motor Cortex: A Placebo‐Controlled Crossover Trial. Annals of Neurology, 97(4), 741-752. https://doi.org/10.1002/ana.27159

Vancouver

van der Heide A, Wessel M, Papadopetraki D, Geurts DEM, van Prooije TH, Gommans F, et al. Propranolol Reduces Parkinson's Tremor and Inhibits Tremor‐Related Activity in the Motor Cortex: A Placebo‐Controlled Crossover Trial. Annals of Neurology. 2025;97(4):741-752. doi:10.1002/ana.27159

BibTeX
@article{vanderHeide2025,
  author = {van der Heide, Anouk and Wessel, Maaike and Papadopetraki, Danae and Geurts, Dirk E M and van Prooije, Teije H and Gommans, Frank and Bloem, Bastiaan R and Dirkx, Michiel F and Helmich, Rick C},
  title = {Propranolol Reduces Parkinson's Tremor and Inhibits Tremor‐Related Activity in the Motor Cortex: A Placebo‐Controlled Crossover Trial},
  journal = {Annals of Neurology},
  year = {2025},
  volume = {97},
  number = {4},
  pages = {741--752},
  doi = {10.1002/ana.27159}
}
Kostenlos starten →